SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-016278
Filing Date
2023-10-06
Accepted
2023-10-06 14:56:04
Documents
13
Period of Report
2023-10-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ampe-20231005x8k.htm   iXBRL 8-K 33766
2 EX-99.1 ampe-20231005xex99d1.htm EX-99.1 23429
  Complete submission text file 0001558370-23-016278.txt   185531

Data Files

Seq Description Document Type Size
3 EX-101.SCH ampe-20231005.xsd EX-101.SCH 3370
4 EX-101.LAB ampe-20231005_lab.xml EX-101.LAB 16023
5 EX-101.PRE ampe-20231005_pre.xml EX-101.PRE 10803
7 EXTRACTED XBRL INSTANCE DOCUMENT ampe-20231005x8k_htm.xml XML 4858
Mailing Address 9800 MOUNT PYRAMID COURT, SUITE 400 ENGLEWOOD CO 80112
Business Address 9800 MOUNT PYRAMID COURT, SUITE 400 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35182 | Film No.: 231313975
SIC: 2834 Pharmaceutical Preparations